Matthew Jonathan Chapin,Mark Barry Abelson,Keith Jeffrey Lane,Akimitsu Makino
申请号:
US11796278
公开号:
US08685439B2
申请日:
2007.04.26
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The invention features novel topical ophthalmic formulations comprising an osmotically active agent and a vasoconstrictor. Suitable osmotically active agents for use in the ophthalmic formulations of the invention include, without limitation, sodium chloride, dextrose, glycerine, sucrose, mannitol, and sorbitol suitable vasoconstritors include, without limitation, naphazoline and oxymetazoline. Also provided are methods of using the ophthalmic formulations of the invention for the treatment and prevention of eyelid swelling by administering the ophthalmic formulations of the invention to the eye surface of a subject in need thereof.